Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NaCl 3% vs Standard Therapy in Moderate to Severe Bronchiolitis
NCT01812525Phase 3Completed
- Start
- Mar 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hypertonic saline in bronchiolitis (2 arms). Primary endpoint: Length of hospital stay at 2 years. Started Mar 2013; status: completed.
02
Drugs
hypertonic saline
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on NCT01812525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01812525.